356 related articles for article (PubMed ID: 24713984)
1. Adrenocortical carcinoma: review and update.
Erickson LA; Rivera M; Zhang J
Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
3. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors?
Dehner LP; Hill DA
Pediatr Dev Pathol; 2009; 12(4):284-91. PubMed ID: 19326954
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
5. Challenges in surgical pathology of adrenocortical tumours.
Erickson LA
Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
[TBL] [Abstract][Full Text] [Related]
7. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in adrenocortical neoplasia.
Assie G; Giordano TJ; Bertherat J
Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
[TBL] [Abstract][Full Text] [Related]
9. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Ribeiro RC; Pinto EM; Zambetti GP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
[TBL] [Abstract][Full Text] [Related]
10. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
12. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
[TBL] [Abstract][Full Text] [Related]
13. Oncocytic adrenocortical carcinoma.
Ohtake H; Kawamura H; Matsuzaki M; Yokoyama E; Kitajima M; Onizuka S; Yamakawa M
Ann Diagn Pathol; 2010 Jun; 14(3):204-8. PubMed ID: 20471567
[TBL] [Abstract][Full Text] [Related]
14. Pathological and molecular features of adrenocortical carcinoma: an update.
Volante M; Buttigliero C; Greco E; Berruti A; Papotti M
J Clin Pathol; 2008 Jul; 61(7):787-93. PubMed ID: 18430754
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
16. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
17. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging therapies for adrenocortical carcinoma--review.
Przytulska J; Rogala N; Bednarek-Tupikowska G
Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
[TBL] [Abstract][Full Text] [Related]
19. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.
Magro G; Esposito G; Cecchetto G; Dall'Igna P; Marcato R; Gambini C; Boldrini R; Collini P; D'Onofrio V; Salfi N; d'Amore E; Ferrari A; Bisogno G; Alaggio R
Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.
Wanis KN; Kanthan R
World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
